The synthesis of complex pharmaceutical compounds often involves multiple steps, with the quality of each intermediate directly influencing the success of the overall process. For the antibiotic Amikacin, a crucial component in combating serious bacterial infections, the intermediate 2-Hydroxy-4-amino Butanoic Acid (CAS 13477-53-7) plays a pivotal role. Understanding its chemical properties and the importance of sourcing it from reliable manufacturers is essential for pharmaceutical companies.

2-Hydroxy-4-amino Butanoic Acid is a key building block, providing a specific structural motif necessary for the formation of Amikacin. Manufacturers typically provide this compound with a high assay, often exceeding 98.0%, presented as a white to off-white crystalline powder. These specifications are critical for ensuring the intended chemical reactions proceed efficiently and without generating unwanted byproducts. For researchers and production managers, searching for terms like 'Amikacin synthesis intermediate' or 'buy high-purity chemical' is standard practice.

The efficacy and safety of Amikacin are directly tied to the purity of its precursors. Therefore, selecting a manufacturer that adheres to stringent quality control measures is paramount. Companies looking to purchase this intermediate often seek out suppliers with a proven track record in the pharmaceutical intermediate market. For instance, NINGBO INNO PHARMCHEM CO.,LTD. aims to be a dependable supplier, offering competitive pricing for bulk quantities and ensuring consistent quality from their facilities in China.

The procurement process for such critical intermediates requires careful consideration. Beyond the chemical specifications, factors such as packaging, storage recommendations, and the availability of technical documentation (like MSDS and CoA) are important. When engaging with potential suppliers, asking for a quote and discussing delivery logistics ensures that your production timelines are met.

In essence, the successful synthesis of Amikacin relies on the consistent availability of high-quality 2-Hydroxy-4-amino Butanoic Acid. By prioritizing reliable suppliers and understanding the critical role of this intermediate, pharmaceutical manufacturers can ensure the integrity and effectiveness of their final drug products, contributing to better patient outcomes worldwide.